The drs tumor suppressor regulates glucose metabolism via lactate dehydrogenase-B

Molecular Carcinogenesis

Volumn 55, Issue 1, 2016, Pages 52-63

  Tambe, Yukihiro ^a   Hasebe, Masahiro ^a,b   Kim, Chul Jang ^c   Yamamoto, Akitsugu ^b   Inoue, Hirokazu ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b NAGAHAMA INSTITUTE OF BIO SCIENCE AND TECHNOLOGY   (Japan)

^c Kohka Public Hospital   (Japan)

Author keywords

drs; Knockout mouse; Lactate dehydrogenase; Warburg effect

Indexed keywords

LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE B; LACTIC ACID; UNCLASSIFIED DRUG; GLUCOSE; ISOENZYME; LACTATE DEHYDROGENASE 1; MEMBRANE PROTEIN; SRPX PROTEIN, MOUSE;

ACIDIFICATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; DRS GENE; EMBRYO; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; FIBROBLAST; GENE EXPRESSION; GLUCOSE INTAKE; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; MALE; METABOLOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSFORMED CELL; TUMOR SUPPRESSOR GENE; ANIMAL; CELL PROLIFERATION; CLUSTER ANALYSIS; GENE INACTIVATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; METABOLOME; NEOPLASM; PROCEDURES; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CLUSTER ANALYSIS; FEMALE; GENE KNOCKOUT TECHNIQUES; GENES, TUMOR SUPPRESSOR; GLUCOSE; HUMANS; ISOENZYMES; L-LACTATE DEHYDROGENASE; MALE; MEMBRANE PROTEINS; METABOLOME; METABOLOMICS; MICE; MICE, KNOCKOUT; NEOPLASMS;

EID: 84954398881     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22258     Document Type: Article

References (44)

1. Pan J, Nakanishi K, Yutsudo M, et al. Isolation of a novel gene down-regulated by v-src. FEBS Lett 1996; 383:21-25.
2. Inoue H, Pan J, Hakura A. Suppression of v-src transformation by the drs gene. J Virol 1998; 72:2532-2537.
3. Yamashita A, Hakura A, Inoue H. Suppression of anchorage-independent growth of human cancer cell lines by the drs gene. Oncogene 1999; 18:4777-4787.
4. Shimakage M, Kawahara K, Kikkawa N, Sasagawa T, Yutsudo M, Inoue H. Down-regulation of drs mRNA in human colon adenocarcinomas. Int J Cancer 2000; 87:5-11.
5. Shimakage M, Takami K, Kodama K, Mano M, Yutsudo M, Inoue H. Expression of drs mRNA in human lung adenocarcinomas. Hum Pathol 2002; 33:615-619.
6. Mukaisho K, Suo M, Shimakage M, Kushima R, Inoue H, Hattori T. Down-regulation of drs mRNA in colorectal neoplasms. Jpn J Cancer Res 2002; 93:888-893.
7. Kim CJ, Shimakage M, Kushima R, et al. Down-regulation of drs mRNA in human prostate carcinomas. Hum Pathol 2003; 34:654-657.
8. Shimakage M, Inoue N, Ohshima K, et al. Downregulation of drs mRNA expression is associated with the progression of adult T-cell leukemia/lymphoma. Int J Oncol 2007; 30:1343-1348.
9. Shimakage M, Kodama K, Kawahara K, et al. Downregulation of drs tumor suppressor gene in highly malignant human pulmonary neuroendocrine tumors. Oncol Rep 2009; 21:1367-1372.
10. Tambe Y, Yoshioka-Yamashita A, Mukaisho K, et al. Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs. Carcinogenesis 2007; 28:777-784.
11. Tambe Y, Isono T, Haraguchi S, Yoshioka-Yamashita A, Yutsudo M, Inoue H. A novel apoptotic pathway induced by the drs tumor suppressor gene. Oncogene 2004; 23:2977-2987.
12. Tambe Y, Yamamoto A, Isono T, Chano T, Fukuda M, Inoue H. The drs tumor suppressor is involved in the maturation process of autophagy induced by low serum. Cancer Lett 2009; 283:74-83.
13. Tambe Y, Okuyama N, Nakagawa T, et al. Suppression of viral replication by drs tumor suppressor via mTOR dependent pathway. Cancer Lett 2012; 314:82-91.
14. Warburg O. On the origin of cancer cells. Science 1956; 123:309-314.
15. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008; 134:703-707.
16. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029-1033.
17. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011; 11:85-95.
18. Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010; 330:1340-1344.
19. Dang CV. Links between metabolism and cancer. Genes Dev 2012; 26:877-890.
20. Bensaad K, Tsuruta A, Selak MA, et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006; 126:107-120.
21. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004; 64:2627-2633.
22. Dang CV. PKM2 tyrosine phosphorylation and glutamine metabolism signal a different view of the Warburg effect. Sci Signal 2009; 2:pe75.
23. Schulze A, Downward J. Flicking the Warburg switch-tyrosine phosphorylation of pyruvate dehydrogenase kinase regulates mitochondrial activity in cancer cells. Mol Cell 2011; 44:846-848.
24. Shim H, Dolde C, Lewis BC, et al. C-Myc transactivation of LDH-A: Implications for tumor metabolism and growth. Proc Natl Acad Sci U S A 1997; 94:6658-6663.
25. Sun Q, Chen X, Ma J, et al. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc Natl Acad Sci U S A 2011; 108:4129-4134.
26. Gao P, Tchernyshyov I, Chang TC, et al. C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458:762-765.
27. Naviaux RK, Costanzi E, Haas M, Verma IM. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 1996; 70:5701-5705.
28. Sugimoto M, Hirayama A, Robert M, Abe S, Soga T, Tomita M. Prediction of metabolite identity from accurate mass, migration time prediction and isotopic pattern information in CE-TOFMS data. Electrophoresis 2010; 31:2311-2318.
29. Pathak C, Jaiswal YK, Vinayak M. Modulation in the activity of lactate dehydrogenase and level of c-Myc and c-Fos by modified base queuine in cancer. Cancer Biol Ther 2008; 7:85-91.
30. Zha X, Wang F, Wang Y, et al. Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis. Cancer Res 2011; 71:13-18.
31. Minami K, Tambe Y, Watanabe R, et al. Suppression of viral replication by stress-inducible GADD34 protein via the mammalian serine/threonine protein kinase mTOR pathway. J Virol 2007; 81:11106-11115.
32. Chen M, Zhou K, Chen X, et al. Metabolomic analysis reveals metabolic changes caused by bisphenol A in rats. Toxicol Sci 2014; 138:256-267.
33. Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J 2011; 435:297-312.
34. Li SS. Human and mouse lactate dehydrogenase genes A (muscle), B (heart), and C (testis): Protein structure, genomic organization, regulation of expression, and molecular evolution. Prog Clin Biol Res 1990; 344:75-99.
35. Pelicano H, Martin DS, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006; 25:4633-4646.
36. Alhopuro P, Sammalkorpi H, Niittymaeki I, et al. Candidate driver genes in microsatellite-unstable colorectal cancer. Int J Cancer 2012; 130:1558-1566.
37. Landi MT, Dracheva T, Rotunno M, et al. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One 2008; 3:e1651.
38. McCleland ML, Adler AS, Shang Y, et al. An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer. Cancer Res 2012; 72:5812-5823.
39. Dennison JB, Molina JR, Mitra S, et al. Lactate dehydrogenase B: A metabolic marker of response to neoadjuvant chemotherapy in breast cancer. Clin Cancer Res 2013; 19:3703-3713.
40. McCleland ML, Adler AS, Deming L, et al. Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas. Clin Cancer Res 2013; 19:773-784.
41. Kinoshita T, Nohata N, Yoshino H, et al. Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma. Int J Oncol 2012; 40:185-193.
42. Mirebeau-Prunier D, Le Pennec S, Jacques C, et al. Estrogen-related receptor alpha modulates lactate dehydrogenase activity in thyroid tumors. PLoS One 2013; 8:e58683.
43. Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D. RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer 2011; 11:761-774.
44. Fernández-Medarde A, Santos E. Ras in cancer and developmental diseases. Genes Cancer 2011; 2:344-358.